Adipokines as biomarkers in paediatric acute pancreatitis: a prospective exploratory single-centre observational study
- 1Department of Paediatrics, Gastroenterology, Hepatology, Nutrition, Allergology and Pulmonology, Medical University of Bialystok, Bialystok, Poland
Abstract
Background: Adipokines are involved in inflammatory response, including pathogenesis of acute pancreatitis (AP). Studies in adults suggest their potential role as biomarkers of AP severity and clinical course.
Objective: To evaluate the utility of adiponectin, resistin, visfatin, and fibroblast growth factor-21 (FGF-21) as biomarkers in paediatric AP, with regard to disease severity and nutritional status.
Materials and methods: This prospective observational exploratory study included children with AP hospitalised between 2020 and 2024 and normal-weight controls with functional abdominal pain. Adipokine concentrations were compared between groups and according to nutritional status, and disease severity. Receiver operating characteristic analysis and univariate logistic regression were performed to evaluate the discriminatory performance and associations of adipokines and conventional inflammatory markers.
Results: The study included 57 children diagnosed with AP and 33 controls; 18 patients with AP were overweight or obese. AP was classified as mild in 46 patients, moderately severe in 10, and severe in 1 child. No statistically significant differences in adipokine concentrations between children with AP and controls, as well as between AP patients with overweight or obesity and normal body weight remained after correction for multiple comparisons. Moderate-to-severe AP was associated with higher visfatin concentration after 72 h (0.48 vs 0.28 ng/mL) and higher conventional inflammatory markers. Visfatin after 72 h demonstrated moderate discriminatory performance for identifying moderate-to-severe AP (AUC = 0.752, 95% CI: 0.612–0.893; p < 0.001). In logistic regression, only conventional inflammatory markers predicted AP severity.
Conclusion: Although selected adipokines were associated with inflammatory and metabolic alterations in paediatric AP, none demonstrated superior discriminatory performance compared with conventional inflammatory markers.
Related
- Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study
- Comparing the efficacy and safety of raltitrexed combined with irinotecan administered in different dose-schedule patterns for the second-line treatment of metastatic colorectal cancer: an exploratory, observational post hoc analysis from the prospective SALLY registry cohort.
- Diagnostic and prognostic blood hormone biomarkers in vestibular disorders: protocol for a prospective observational cohort study at a tertiary referral centre in Germany
- Bioelectrical Impedance Analysis–Derived Phase Angle in Initial Medical and Nursing Assessment for Cardiac Rehabilitation: Association with Cardiac Rehabilitation Risk Category and Longitudinal Change During the Program—An Exploratory Prospective Observational Study
- Associations between the development of severe acute pancreatitis and the risk scores on admission and inflammatory biomarkers in older patients: a retrospective cohort study
BibTeX
@article{kwiateksredzinska2026adipokines,
title = {{Adipokines as biomarkers in paediatric acute pancreatitis: a prospective exploratory single-centre observational study}},
author = {Kamila Agnieszka Kwiatek-Średzińska and Mirosława Uścinowicz and Dariusz Marek Lebensztejn},
journal = {Annals of Medicine},
year = {2026},
month = nov,
doi = {10.1080/07853890.2026.2743316},
url = {https://doi.org/10.1080/07853890.2026.2743316},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Adipokines as biomarkers in paediatric acute pancreatitis: a prospective exploratory single-centre observational study
AU - Kamila Agnieszka Kwiatek-Średzińska
AU - Mirosława Uścinowicz
AU - Dariusz Marek Lebensztejn
PY - 2026
DA - 2026/11/09
JO - Annals of Medicine
DO - 10.1080/07853890.2026.2743316
UR - https://doi.org/10.1080/07853890.2026.2743316
AB - Background: Adipokines are involved in inflammatory response, including pathogenesis of acute pancreatitis (AP). Studies in adults suggest their potential role as biomarkers of AP severity and clinical course. Objective: To evaluate the utility of adiponectin, resistin, visfatin, and fibroblast growth factor-21 (FGF-21) as biomarkers in paediatric AP, with regard to disease severity and nutritional status. Materials and methods: This prospective observational exploratory study included children with AP hospitalised between 2020 and 2024 and normal-weight controls with functional abdominal pain. Adipokine concentrations were compared between groups and according to nutritional status, and disease severity. Receiver operating characteristic analysis and univariate logistic regression were performed to evaluate the discriminatory performance and associations of adipokines and conventional inflammatory markers. Results: The study included 57 children diagnosed with AP and 33 controls; 18 patients with AP were overweight or obese. AP was classified as mild in 46 patients, moderately severe in 10, and severe in 1 child. No statistically significant differences in adipokine concentrations between children with AP and controls, as well as between AP patients with overweight or obesity and normal body weight remained after correction for multiple comparisons. Moderate-to-severe AP was associated with higher visfatin concentration after 72 h (0.48 vs 0.28 ng/mL) and higher conventional inflammatory markers. Visfatin after 72 h demonstrated moderate discriminatory performance for identifying moderate-to-severe AP (AUC = 0.752, 95% CI: 0.612–0.893; p < 0.001). In logistic regression, only conventional inflammatory markers predicted AP severity. Conclusion: Although selected adipokines were associated with inflammatory and metabolic alterations in paediatric AP, none demonstrated superior discriminatory performance compared with conventional inflammatory markers.
SN - 0785-3890
SN - 1365-2060
ER -